GlassScriptPhysician profile
Luis J Sanchez-Robles
NPI 1073587010
$14,664.32
in general payments reported to CMS, 2019-2025
36 companies · $1,699 in 2025
The $1,699 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $827 · 2020: $673 · 2021: $732 · 2022: $2,737 · 2023: $7,129 · 2024: $867 · 2025: $1,699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,762 · Food and Beverage: $3,492 · Travel and Lodging: $2,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,761.78 |
| Food and Beverage | $3,491.72 |
| Travel and Lodging | $2,441.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $4,160.11 | 2023 | |
| Orthofix Medical, INC. | $1,392.98 | 2023-2024 | Truelok, Truelok System |
| Reel Surgical, INC. | $1,200.00 | 2022 | |
| Arthrex, INC. | $1,186.56 | 2025 | |
| Stryker Corporation | $1,178.38 | 2019-2024 | Valor |
| Paragon 28, INC. | $532.51 | 2019-2024 | Phantom Hindfoot, Silverback |
| Arteriocyte Medical Systems, INC. | $506.81 | 2019-2020 | |
| Integra Lifesciences Corporation | $457.68 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $428.65 | 2021-2024 | Stravix, Grafix Pl, Grafix |
| Linvatec Corporation | $421.20 | 2023-2025 | Quantum, Colink 2, Neospan Superelastic Compression Staple W/Instruments, Size 10x10x10 |
| Voom Medical Devices, INC. | $390.95 | 2024 | Revcon |
| Bioventus LLC | $384.79 | 2022-2025 | Stimrouter Implantable Kit, Stimrouter Implantable Kit |
| Depuy Synthes Sales INC. | $367.70 | 2020-2023 | Na |
| Organogenesis INC. | $197.09 | 2019-2022 | |
| Convatec INC. | $188.57 | 2023 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $182.75 | 2021-2023 | Avance Nerve Graft |
| Flower Orthopedics Coporation | $149.92 | 2023 | |
| In2bones USA, LLC | $148.50 | 2022 | |
| Kerecis Limited | $144.89 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $143.66 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $130.23 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $127.44 | 2023 | |
| Wright Medical Technology, INC. | $98.32 | 2019-2020 | |
| Crossroads Extremity Systems, LLC | $83.33 | 2020 | |
| Fusion Orthopedics USA, LLC | $68.20 | 2025 | |
| Life Spine, INC. | $67.19 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $65.22 | 2022 | |
| Acera Surgical, INC. | $61.66 | 2022-2023 | Restrata Wound Matrix |
| Next Science LLC | $42.53 | 2023 | Blastx, Xperience, Surgx |
| Curonix LLC | $33.54 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ossio INC | $25.74 | 2022 | |
| Zyla Life Sciences, INC. | $25.41 | 2019 | |
| Averitas Pharma INC. | $22.01 | 2023 | Qutenza |
| Embody, INC. | $19.73 | 2022 | |
| Horizon Therapeutics Plc | $15.16 | 2019 | |
| Merck Sharp & Dohme LLC | $14.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Sanchez-Robles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.